NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-17
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 6394766 or send an email
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-17
The Centers for Disease Control and Prevention (CDC) publishes a
list of information collection requests under review by the Office of
Management and Budget (OMB) in compliance with the Paperwork Reduction
Act (44 U.S.C. Chapter 35). To request a copy of these requests, call
the CDC Reports Clearance Officer at (404) 6394766 or send an email
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-17
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
NOTICES: International Conference on Harmonisation—; Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions,
Published: 2007-12-17
The Food and Drug Administration (FDA) is announcing the
availability of a draft guidance entitled ``Q4B Evaluation and
Recommendation of Pharmacopoeial Texts for Use in the ICH Regions;
Annex 3: Test for Particulate Contamination: Subvisible Particles
General Chapter.'' The draft guidance was prepared under the auspices
of the International
NOTICES: International Conference on Harmonisation—; Q4B evaluation and recommendation of pharmacopoeial texts for use in the ICH regions,
Published: 2007-12-17
The Food and Drug Administration (FDA) is announcing the
availability of a draft guidance entitled ``Q4B Evaluation and
Recommendation of Pharmacopoeial Texts for Use in the ICH Regions;
Annex 2: Test for Extractable Volume of Parenteral Preparations General
Chapter.'' The draft guidance was prepared under the auspices of the
International
NOTICES: Platelets collection by automated methods; FDA Review Staff guidance,
Published: 2007-12-17
The Food and Drug Administration (FDA) is announcing the
availability of a document entitled ``Guidance for Industry and FDA
Review Staff: Collection of Platelets by Automated Methods,'' dated
December 2007. The guidance document provides to blood establishments
and FDA staff revised recommendations for the collection of Platelets
by automated
NOTICES: Disease Management Outcomes Measurement,
Published: 2007-12-17
This notice announces the date and location of the Department
of Health and Human Services, Office of the Assistant Secretary for
Planning and Evaluation (HHS/ASPE) Expert Meeting on Disease Management
Outcomes Measurement. The objective of the meeting is to convene a
panel of experts from government, academia, and private industry to
discuss
NOTICES: National Heart, Lung, and Blood Institute,
Published: 2007-12-17
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions
NOTICES: Health information technology: interoperability standards,
Published: 2007-12-17
This notice identifies three (3) additional Consolidated
Health Informatics (CHI) messaging and vocabulary standards
(Multimedia, Allergy, and Disability and Assessments) adopted for use
in Federal government health information technology systems. This work
supplements the work to further the adoption of the first set of 5
standards adopted on
NOTICES: Special Exposure Cohort; employee class designations—; Pantex Plant, TX,
Published: 2007-12-17
The Department of Health and Human Services (HHS) gives notice
as required by 42 CFR 83.12(e) of a decision to evaluate a petition to
designate a class of employees at the Pantex Plant, Amarillo, Texas, to
be included in the Special Exposure Cohort under the Energy Employees
Occupational Illness Compensation Program Act of 2000. The initial
NOTICES: Agency information collection activities; proposals, submissions, and approvals,
Published: 2007-12-17
In compliance with the requirement for the opportunity for public
comment on proposed data collection projects [Section 3506 (c)(2)(A) of
Title 44, United States Code, as amended by the Paperwork Reduction Act
of 1995, Pub. L. 10413], the Health Resources and Services
Administration (HRSA) publishes periodic summaries of proposed projects
NOTICES: Chase Brexton Health Services,
Published: 2007-12-17
HRSA will be providing temporary critical HIV medical care and
treatment services through Chase Brexton Health Services to avoid a
disruption of HIV clinical care to homeless populations in the
Baltimore, Maryland, area.